Rebeccamycin derivatives as dual DNA-damaging agents and potent checkpoint kinase 1 inhibitors.
Marminon C, Anizon F, Moreau P, Pfeiffer B, Pierré A, Golsteyn RM, Peixoto P, Hildebrand MP, David-Cordonnier MH, Lozach O, Meijer L, Prudhomme M.
Marminon C, et al. Among authors: hildebrand mp.
Mol Pharmacol. 2008 Dec;74(6):1620-9. doi: 10.1124/mol.108.049346. Epub 2008 Sep 2.
Mol Pharmacol. 2008.
PMID: 18768386